98079248 - CENMIRA

Information

• Trademark
• 98079248

• Source

• Serial Number

  98079248

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  July 11, 2023
  10 months ago

• Transaction Date

  December 19, 2023
  5 months ago

• Status Date

  December 19, 2023
  5 months ago

• Published for Opposition Date

  October 24, 2023
  7 months ago

• Location Date

  December 19, 2023
  5 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  MCCARTHY, JOSEPH PATRI

• Attorney Name

  Laurence Rickles

  Law Office Assigned Location Code

  N90

• Owners

  • Teva Pharmaceutical Industries Ltd.

Case File Statements

• GS0051: Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

Case File Event Statements

• 12/19/2023 - 5 months ago

  9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 10/24/2023 - 7 months ago

  8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/24/2023 - 7 months ago

  7 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/4/2023 - 7 months ago

  6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/20/2023 - 8 months ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/18/2023 - 8 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/16/2023 - 9 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/9/2023 - 9 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/14/2023 - 10 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP